Other GLP-1s may be considered off-label when clinically appropriate
The majority of adverse effects were mild, and only two patients discontinued treatment due to gastrointestinal side effects
Many patients will still require CPAP therapy, Inspire, or other interventions, especially if sleep apnea is caused by anatomical or neurological issues, not just weight
Semaglutide Injections (Injectable GLP-1): Nausea: Similar to tablets, nausea is a prevalent side effect
Researchers following the retatrutide weight loss protocol should reassess their injection sites every 4 to 6 weeks as their body composition changes
If you have a family history of medullary thyroid cancer, multiple endocrine neoplasias, or acute pancreatitis, you should avoid GLP-1 drugs [1,2,4]